Propanc Biopharma, Inc.: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 20, 2014 and accepted by EDGAR at May 20, 2014, 09:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 3 months2014-01-01 to 2014-03-31 | −$104.3k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-07-01 to 2014-03-31 | −$638.3k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-01-01 to 2014-03-31 | $19.9k | us-gaap:InterestExpense |
| Interest expense | 9 months2013-07-01 to 2014-03-31 | $42.3k | us-gaap:InterestExpense |
| Income tax | 9 months2013-07-01 to 2014-03-31 | −$48.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-01-01 to 2014-03-31 | −$66.9k | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-07-01 to 2014-03-31 | −$612.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2013-07-01 to 2014-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2013-07-01 to 2014-03-31 | −$137.7k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2014-03-31 | $40 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-03-31 | $40 | us-gaap:AssetsCurrent |
| Total assets | At period end2014-03-31 | $40 | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $1.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2014-03-31 | −$1.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-14-002818. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.